Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021 | medRxiv

View the discussion thread.

Posted December 15, 2021.

Subject Area

Epidemiology

Subject Areas

All Articles

Addiction Medicine (399)
Allergy and Immunology (708)
Anesthesia (200)
Cardiovascular Medicine (2918)
Dentistry and Oral Medicine (333)
Dermatology (249)
Emergency Medicine (438)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1032)
Epidemiology (12711)
Forensic Medicine (12)
Gastroenterology (827)
Genetic and Genomic Medicine (4567)
Geriatric Medicine (415)
Health Economics (726)
Health Informatics (2913)
Health Policy (1068)
Health Systems and Quality Improvement (1074)
Hematology (386)
HIV/AIDS (922)
Infectious Diseases (except HIV/AIDS) (14081)
Intensive Care and Critical Care Medicine (842)
Medical Education (422)
Medical Ethics (115)
Nephrology (467)
Neurology (4335)
Nursing (234)
Nutrition (636)
Obstetrics and Gynecology (801)
Occupational and Environmental Health (734)
Oncology (2261)
Ophthalmology (643)
Orthopedics (258)
Otolaryngology (324)
Pain Medicine (278)
Palliative Medicine (83)
Pathology (499)
Pediatrics (1196)
Pharmacology and Therapeutics (502)
Primary Care Research (494)
Psychiatry and Clinical Psychology (3734)
Public and Global Health (6916)
Radiology and Imaging (1524)
Rehabilitation Medicine and Physical Therapy (895)
Respiratory Medicine (915)
Rheumatology (436)
Sexual and Reproductive Health (443)
Sports Medicine (383)
Surgery (486)
Toxicology (60)
Transplantation (210)
Urology (178)